We are live on ! Find out more
FMS icon

Fresenius Medical Care

189 hedge funds and large institutions have $770M invested in Fresenius Medical Care in 2024 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 63 increasing their positions, 43 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 14

117% more call options, than puts

Call options by funds: $1.31M | Put options by funds: $602K

47% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 43

13% more funds holding

Funds holding: 167189 (+22)

8% more capital invested

Capital invested by funds: $713M → $770M (+$56.9M)

0.19% more ownership

Funds ownership: 11.41%11.59% (+0.19%)

Holders
189
Holders Change
+22
Holders Change %
+13.17%
% of All Funds
2.49%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
38
Increased
63
Reduced
43
Closed
14
Calls
$1.31M
Puts
$602K
Net Calls
+$704K
Net Calls Change
+$344K
Name Holding Trade Value Shares
Change
Change in
Stake
Natixis Advisors
76
Natixis Advisors
Massachusetts
$332K +$318K +14,667 New
WHC
77
Wulff, Hansen & Co
California
$332K -$35.9K -1,655 -10%
Mercer Global Advisors
78
Mercer Global Advisors
Colorado
$329K +$1.22K +56 +0.4%
LPAM
79
Lodestar Private Asset Management
California
$319K -$6.51K -300 -2%
Qube Research & Technologies (QRT)
80
Qube Research & Technologies (QRT)
United Kingdom
$304K +$292K +13,441 New
EHC
81
Everett Harris & Co
California
$300K -$7.38K -340 -3%
Commonwealth Equity Services
82
Commonwealth Equity Services
Massachusetts
$300K +$1.15K +53 +0.4%
CC
83
Callan Capital
California
$297K +$284K +13,104 New
Squarepoint
84
Squarepoint
New York
$290K +$278K +12,823 New
CP
85
Castleview Partners
Texas
$284K -$96.8K -4,458 -26%
AQR Capital Management
86
AQR Capital Management
Connecticut
$283K +$272K +12,520 New
CCIA
87
Campbell & Co Investment Adviser
Maryland
$262K -$422K -19,419 -63%
SC
88
Syon Capital
California
$262K +$251K +11,552 New
Ameriprise
89
Ameriprise
Minnesota
$261K -$5.38K -248 -2%
FFM
90
Forum Financial Management
Illinois
$247K +$236K +10,891 New
VIA
91
Virtus Investment Advisers
Connecticut
$240K
OCM
92
One Capital Management
California
$237K
SG Americas Securities
93
SG Americas Securities
New York
$230K
LNWWM
94
Laird Norton Wetherby Wealth Management
California
$225K +$1.41K +65 +0.7%
KB
95
Kimelman & Baird
New York
$220K
ClearBridge Investments
96
ClearBridge Investments
New York
$218K -$8.03K -370 -4%
DWT
97
Dorsey & Whitney Trust
South Dakota
$216K +$207K +9,541 New
Neuberger Berman Group
98
Neuberger Berman Group
New York
$214K +$206K +9,470 New
PNC Financial Services Group
99
PNC Financial Services Group
Pennsylvania
$210K +$9.6K +442 +5%
AGP
100
Autumn Glory Partners
Texas
$208K +$200K +9,198 New

FMS Hedge Fund Activity: Q4 2024 in Review

189 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Fresenius Medical Care (FMS) for Q4 2024, worth a combined $770M — up 8% from $713M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new FMS positions and 14 closed out — a net gain of 24 holders — while 63 added to existing stakes and 43 trimmed.

The largest buyer was Millennium Management, adding an estimated $15.4M. The largest seller was Pzena Investment Management, cutting an estimated $20.2M.

  • 189 institutional investors held Fresenius Medical Care (FMS) as of Q4 2024, up from 167 in Q3 2024.
  • Funds reported $770M of Fresenius Medical Care stock for Q4 2024, up 8% quarter-over-quarter.
  • 38 funds opened new Fresenius Medical Care positions in Q4 2024 and 14 closed out, a net change of +24 holders.
  • The largest Fresenius Medical Care buyer in Q4 2024 was Millennium Management, an estimated $15.4M added.
  • The largest Fresenius Medical Care seller in Q4 2024 was Pzena Investment Management, an estimated $20.2M sold.

Based on aggregated 13F filings for Q4 2024.